Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a leading RNAi therapeutics company, announced that the European Patent Office (EPO) has upheld the McSwiggen EP 1423406 (’406) patent in oral opposition proceedings in Munich, Germany. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock opened today at $64.37 and is currently trading at $64.40. The stock showed a positive weekly performance of 0.43%.
Imperva, Inc. (NYSE:IMPV) said it expects to report total revenue for the first quarter of 2014 in the range of USD31.0m to USD31.5m compared to the company´s prior guidance of total revenue in the range of USD36.0m to USD37.0m. Imperva Inc (NYSE:IMPV) stock opened at $32.05, in current trading session and currently is at $30.81, by losing -37.98%. The 52 week range is $30.27 – $67.12. Company’s market capitalization is $803.05 million.
International Business Machines Corp. (NYSE:IBM)‘s stock had its “hold” rating restated by equities research analysts at Deutsche Bank in a research note issued to investors on Thursday, Stock Ratings Networkreports. International Business Machines Corp. (NYSE:IBM) stock is currently trading at $197.40. The EPS of the stock is 15.07. Company’s market capitalization is $205.47 billion.
Organovo Holdings Inc (NYSE:ONVO) paid millions to brokers with fraudulent histories to promote shares to individual investors. Organovo Holdings Inc (NYSE:ONVO) has spent nearly 3x as much on selling shares and promoting its stock as it has on Research & Development since the company was founded. Organovo Holdings Inc (NYSEMKT:ONVO) stock opened the session at $8.67, and now is at $8.52. The 52 week range of the stock remained $3.34 – $13.65 and the day range was $8.40 – $8.67.
Leave a Reply